Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2005-01-28
2008-11-18
Haghighatian, Mina (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S043000, C424S434000
Reexamination Certificate
active
07452523
ABSTRACT:
An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 μm to 10 μm and a geometric standard deviation less than 1.7 using an electronic nebulizer.
REFERENCES:
patent: 5837713 (1998-11-01), Gleich
patent: 6362197 (2002-03-01), Page et al.
patent: 6576224 (2003-06-01), Osbakken et al.
patent: 6962151 (2005-11-01), Knoch et al.
patent: 7208141 (2007-04-01), Montgomery
patent: 2003/0133925 (2003-07-01), Shawar
patent: 2003/0171402 (2003-09-01), Gleich et al.
Pari, eFlow, News Relaese, May 18, 2004.
Weiss et al, The response to lidocaine in bronchial asthma,. Chest, 72: 4, Cot. 1977, pp. 429-438.
Lisa A. Whims, et al., Nebulized Lidocaine in the Treatment of Refractory Tussive Syncope,JAOA, 98:3, pp. 170-172 (Mar. 1998).
Scott Trochtenberg, Nebulized Lidocaine in the Treatment of Refractory Cough,Chest, 105:5, pp. 1592-1593 (May 1994).
Robert V. Sanders et al., Prolonged Suppression of Cough After Inhalation of Lidocaine in a Patient With Sarcoid,JAMA, 252:17, pp. 2456-2457, (Nov. 2, 1984).
Peter Dure-Smith, et al., Bronchography: The Rational Use Of Premedication and Local Anesthesia,Journal of the Canadian Association of Radiologists, 22:199-200, (Sep. 1971).
Emmanuel Udezue, Lidocaine Inhalation for Cough Suppression,Clinical Notes, pp. 206-207.
F. A. Naveira, et al., Treatment of Persistent Cough After Stellate Ganglion Block,Regional Anesthesia, 18:5, pp. 312-314, (Sep.-Oct. 1993).
J. J. Adcock, et al., RSD931, A Novel Anti-tussive Agent Acting On Airway Sensory Nerves,British Journal of Pharmacology, 138:407-416, (2003).
M. Jeffery Mador, Effect of Nebulized Lidocaine on Ventilatory Response to CO2in Healthy Subjects, pp. 1419-1424, 1993.
Paul L. Enright, et al., Effect of Lidocaine on the Ventilatory and Airway Responses to Exercise in Asthmatics,American Review of Respiratory Disease, 122:823-828, (1980).
D. A. Jones, et al., Plasma Concentrations of Lignocaine and its Metabolites During Fibreoptic Bronchoscopy,Br. J. Anesth., 54:853-857, (1982).
L. Hansson, et al., Effects of Inhaled Lignocaine and Adrenaline on Capsaicin-Induced Cough in Humans,Thorax, 49:1166-1168, (1994).
P. Howard, et al., Lignocaine Aerosol and Persistent Cough,Br. J. Dis. Chest, 71:19-24, (1977).
C. Konrad, et al., Is An Alkalinized Lignocaine Solution a Better Topical Anesthetic for Intratracheal Application?,European Journal of Anesthesiology, 14:616-622, (1997).
Hofmann Thomas
Montgomery Alan Bruce
Stapleton Kevin
Gilead Sciences, Inc.
Haghighatian Mina
Peters Verny LLP
Verny Hana
LandOfFree
Targeted delivery of lidocaine and other local anesthetics... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted delivery of lidocaine and other local anesthetics..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted delivery of lidocaine and other local anesthetics... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4048660